Veristat
About Veristat
Veristat is a company based in Southborough (United States) founded in 1994 was acquired by SFL Regulatory Affairs & Scientific Communication in March 2022. Veristat has completed 9 acquisitions, including Catalyst Regulatory Services, Certus PV and SFL Regulatory Affairs & Scientific Communication. Veristat offers products and services including Strategic Consulting, Regulatory Affairs, Clinical Operations, Medical Writing, and Biometrics. Veristat operates in a competitive market with competitors including Celgene, Syneos Health, Medelis WCCT Global, Emmes and Parexel, among others.
- Headquarter Southborough, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Veristat, Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$1.33 M (USD), Grant
Dec 01, 2021
-
Investors
European Union
& 2 more
-
Employee Count
Not available
-
Investments & Acquisitions
Catalyst Regulatory Services
& 8 more
-
Acquired by
SFL Regulatory Affairs & Scientific Communication
(Mar 07, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Veristat
Veristat offers a comprehensive portfolio of products and services, including Strategic Consulting, Regulatory Affairs, Clinical Operations, Medical Writing, and Biometrics.
Provides advice for clinical development and adaptive designs.
Manages submissions, agency meetings, and compliance for trials.
Oversees project management and patient recruitment processes.
Creates reports and documents for regulatory and trial needs.
Handles data management, biostatistics, and monitoring committees.
People of Veristat
Unlock access to complete
Unlock access to complete
Funding Insights of Veristat
Investors in Veristat
Veristat has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, SFL Regulatory Affairs & Scientific Communication and Variance Development Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
US private equity investments are managed by Variance Development Partners.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Consulting services in regulatory affairs and scientific communication are provided.
|
Locked | Locked | Locked |
Investor details for Veristat
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Veristat
Veristat has strategically engaged in corporate development activities, having acquired 9 companies. Notable acquisitions include Catalyst Regulatory Services, Certus PV and SFL Regulatory Affairs & Scientific Communication.
Investment portfolio details for Veristat
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Pharmacovigilance services are delivered by Certus PV as a CRO.
|
Locked | Locked | 2014 | Locked | |
|
Clinical operations support is provided for oncology trials.
|
Locked | Locked | 2014 | Locked | |
|
Togel Hongkong lottery results are provided by Toto HK.
|
Locked | Locked | 2013 | Locked |
Complete acquisition details for Veristat
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Veristat
Detailed financials for Veristat
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Veristat Comparisons
Peer comparison for Veristat
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Veristat
Veristat operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celgene, Syneos Health, Medelis WCCT Global, Emmes and Parexel, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapies for cancer and inflammatory diseases are developed.
|
|
| Locked | Locked | Locked |
CRO clinical development services are provided by Syneos Health.
|
|
| Locked | Locked | Locked |
Full-service CRO expertise in influenza and oncology research is offered.
|
|
| Locked | Locked | Locked |
Outsourced contract research organization services are provided to clients.
|
|
| Locked | Locked | Locked |
Full-service clinical research organization services are provided globally by Parexel.
|
|
| Locked | Locked | Locked |
Global full-service CRO services are delivered in over 80 countries.
|
Detailed competitors of Veristat
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Veristat
Complete news archive for Veristat
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Veristat
Veristat was founded in 1994 and raised its 1st funding round 19 years after it was founded.
Veristat is headquartered in Southborough, United States. It is registered at Southborough, Massachusetts, United States.
Veristat is a clinical research organization (CRO) supporting clinical trials and regulatory submissions for pharmaceutical, biotechnology, and medical device companies. Its clinical development services include biostatistics, statistical programming, medical writing, clinical monitoring, project management and data management for a single study or an entire clinical program. It also provides services in preparation of integrated summary documents and submission-ready CDISC data for regulatory filings. In May 2016, Veristat acquired UK-based CRO Spero Oncology for an undisclosed amount. The company was recognized for the second consecutive year as one of the top 50 fastest-growing private companies in Massachusetts.
Veristat's top competitors include Emmes, Syneos Health and ClinChoice.
Veristat offers Strategic Consulting, Regulatory Affairs, Clinical Operations, Medical Writing, and Biometrics.
Veristat has made 9 acquisitions, including Catalyst Regulatory Services, Certus PV, and SFL Regulatory Affairs & Scientific Communication.
Veristat has 3 investors. Key investors include European Union, SFL Regulatory Affairs & Scientific Communication, and Variance Development Partners.